Psilocybin - A Drug to be Considered for the Treatment of Anxiety and Depression in Cancer Patients
Journal of Natural Remedies – July 31, 2024
Source: OpenAlex
Summary
For cancer patients struggling with anxiety and depression, conventional antidepressant drugs often fall short, severely impacting their quality of life. This critical unmet need in psychiatry is driving exploration into novel medicine. Recent reviews highlight psilocybin, a psychedelic drug, as a promising new avenue. Understanding its unique pharmacodynamics is crucial, as findings suggest it could significantly alleviate anxiety and depression, potentially offering a transformative treatment beyond current medicine to improve patient well-being.
Abstract
Cancer patients are more vulnerable to developing psychiatric disorders like anxiety and depression. These conditions give an additional burden leading to poor quality of life. The available antidepressant and antianxiety drugs are not very useful in improving quality of life by reducing anxiety and depressive episodes. Therefore, there is a need for good drugs to alleviate the psychiatric problems among cancer patients. The recent reviews deal with the pharmacodynamics, pharmacokinetics and efficacy of psilocybin in the treatment of patients suffering from anxiety and depression.